pillbase.ru

ADCETRIS

Active substance: brentuximab vedotin

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · BRENTUXIMAB VEDOTIN 50 mg/10.5mL

United StatesActive

Marketing holder: SEAGEN INC.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 2
  • Адцетрис®
    лиофилизат для приготовления концентрата для приготовления раствора для инфузий, 50 мг, 50 мг (original in Russian, GRLS)
    ЛП-003476
    Такеда Фарма А/С
  • Адцетрис®
    лиофилизат для приготовления концентрата для приготовления раствора для инфузий, 50 мг, 50 мг (original in Russian, GRLS)
    ЛП-№(001849)-(ГП-RU)
    Такеда Фарма А/С
EU 1
  • Adcetris
    Brentuximab vedotin
    EMEA/H/C/002455
    Takeda Pharma A/S
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-2f8e-794b-b3bf-b23c568987a2,01a120c3-4380-7210-aeb4-97183bc99860;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a12091-bd61-7793-8eb2-5301238a5942;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
51144-050
Registration status
Active
Dispensing
Prescription only
Route
INTRAVENOUS
Sources
  • product · openFDA NDC · 51144-050 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 51144-050 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 51144-050 · Verified 2026-10-09 · open in source